Search research articles
Contact Us
Filters
Showing results (41-50 of 380) with videos related to
Page
of 38
Sort By:
Expert Opinion on Investigational Drugs
|
December 5, 2025
Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?
Iacopo Petrini, Giuseppe Giaccone
Autophagy
|
January 23, 2014
CYB5A and autophagy-mediated cell death in pancreatic cancer
Elisa Giovannetti, Giuseppe Giaccone
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2023
Reply to Dr. Goto's Letter: "A Thymoma Mouse Model Harboring a Gtf2i L424H Mutation"
Yongfeng He, Giuseppe Giaccone
Current Opinion in Oncology
|
February 9, 2012
Treatment of nonsmall cell lung cancer: overcoming the resistance to epidermal growth factor receptor inhibitors
Corey A Carter, Giuseppe Giaccone
Cancer Journal (Sudbury, Mass.)
|
September 29, 2011
Lung cancer vaccines
Ronan J Kelly, Giuseppe Giaccone
The Lancet. Oncology
|
March 3, 2006
Keynote comment: are large-scale cancer-genomics projects ready to use?
Jose Antonio Rodriguez, Giuseppe Giaccone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2015
Next-Generation Sequencing: Targeting Targeted Therapies
Justine N McCutcheon, Giuseppe Giaccone
Nature Reviews. Clinical Oncology
|
January 22, 2014
Lung cancer in 2013: Refining standard practice and admitting uncertainty
Stephen V Liu, Giuseppe Giaccone
Nature Reviews. Clinical Oncology
|
September 14, 2016
Lung cancer: First-line immunotherapy in lung cancer - taking the first step
Stephen V Liu, Giuseppe Giaccone
Nature Reviews. Clinical Oncology
|
July 2, 2010
Targeted therapies: Importance of patient selection for EGFR TKIs in lung cancer
Ariel Lopez-Chavez, Giuseppe Giaccone
Page
of 38
Search research articles
Search
Showing results (41-50 of 380) with videos related to
Sort By:
Page
of 38
Expert Opinion on Investigational Drugs
|
December 5, 2025
Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?
Iacopo Petrini, Giuseppe Giaccone
Autophagy
|
January 23, 2014
CYB5A and autophagy-mediated cell death in pancreatic cancer
Elisa Giovannetti, Giuseppe Giaccone
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2023
Reply to Dr. Goto's Letter: "A Thymoma Mouse Model Harboring a Gtf2i L424H Mutation"
Yongfeng He, Giuseppe Giaccone
Current Opinion in Oncology
|
February 9, 2012
Treatment of nonsmall cell lung cancer: overcoming the resistance to epidermal growth factor receptor inhibitors
Corey A Carter, Giuseppe Giaccone
Cancer Journal (Sudbury, Mass.)
|
September 29, 2011
Lung cancer vaccines
Ronan J Kelly, Giuseppe Giaccone
The Lancet. Oncology
|
March 3, 2006
Keynote comment: are large-scale cancer-genomics projects ready to use?
Jose Antonio Rodriguez, Giuseppe Giaccone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2015
Next-Generation Sequencing: Targeting Targeted Therapies
Justine N McCutcheon, Giuseppe Giaccone
Nature Reviews. Clinical Oncology
|
January 22, 2014
Lung cancer in 2013: Refining standard practice and admitting uncertainty
Stephen V Liu, Giuseppe Giaccone
Nature Reviews. Clinical Oncology
|
September 14, 2016
Lung cancer: First-line immunotherapy in lung cancer - taking the first step
Stephen V Liu, Giuseppe Giaccone
Nature Reviews. Clinical Oncology
|
July 2, 2010
Targeted therapies: Importance of patient selection for EGFR TKIs in lung cancer
Ariel Lopez-Chavez, Giuseppe Giaccone
Page
of 38